BLGO · XBRL financial data

Biolargo financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BLGO's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	—	year only	—	—	—	—	—	—	—	—	—	—
Cost of goods and services sold	1,237	2,282*	2,514	2,877	2,629	1,907*	1,781	1,356	731	489*	657	573
Gross profit	1,435	—	2,246	2,137	1,722	—	1,488	1,421	372	—	458	675
Research and development	694	436*	784	623	690	784*	791	535	615	659*	907	1,088
Selling, general and administrative	2,278	2,264*	2,225	2,404	2,093	2,582*	2,559	2,688	3,088	3,429*	2,755	3,315
Total operating expenses	2,972	3,094*	3,009	3,027	2,783	3,366*	3,350	3,223	7,552	4,139*	3,662	4,403
Operating income (loss)	(1,537)	(1,006)*	(763)	(890)	(1,061)	(1,616)*	(1,862)	(1,802)	(7,180)	(4,011)*	(3,204)	(3,728)
Interest income	—	—	—	4	14	11*	18	36	80	57*	72	13
Interest expense	12	19*	12	2	13	37*	93	115	144	188*	188	285
Other income (expense)	29	(14)*	(12)	110	1	—	—	—	—	—	—	—
Income tax expense (benefit)	—	year only	—	—	—	year only	—	—	—	—	—	—
Earnings per share, basic USD per share	(0.01)	—	(0.00)	(0.00)	(0.00)	—	(0.00)	(0.00)	(0.02)	—	(0.01)	(0.01)
Weighted average shares, basic thousands of shares	287,943	290,103*	294,309	296,436	300,489	301,195*	301,274	303,197	308,974	314,210*	318,699	320,984

Balance sheet

CSV

Fiscal quarters (BLGO's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	3,042	3,539	4,336	4,765	3,882	3,548	2,564	3,471	4,546	3,883	4,122	2,188
Accounts receivable	1,453	2,612	2,473	2,104	3,209	3,168	4,208	1,735	761	615	730	724
Inventory	122	153	251	176	238	330	369	444	409	310	292	303
Prepaid and other current assets	74	58	116	65	65	91	77	51	59	306	301	284
Total current assets	4,691	6,362	7,176	7,110	7,394	7,137	7,218	9,187	5,775	5,114	5,445	3,499
Property and equipment, net	599	662	1,489	1,811	1,807	1,742	1,700	1,664	1,664	1,643	1,641	1,768
Right-of-use asset	777	1,092	1,068	1,044	1,019	992	965	937	1,070	1,028	979	927
Total assets	6,545	8,205	9,821	10,053	10,305	10,513	10,511	12,499	9,130	8,311	8,565	6,669
Accounts payable	670	1,212	1,663	1,473	1,563	826	1,154	1,177	789	1,012	838	874
Current portion of long-term debt	66	—	—	—	—	552	—	83	83	—	—	—
Total current liabilities	1,740	2,710	3,404	3,012	3,200	2,648	3,373	4,080	3,451	5,063	4,932	4,765
Long-term debt	293	289	284	184	180	—	—	—	—	—	—	—
Lease liability, non-current	695	1,004	985	965	944	922	897	872	969	864	808	746
Total liabilities	2,728	4,003	4,673	4,161	4,324	4,457	5,421	6,439	5,915	6,785	8,752	9,399
Accumulated deficit	(146,369)	(147,098)	(147,508)	(147,949)	(148,486)	(149,500)	(150,655)	(151,848)	(158,327)	(161,280)	(163,566)	(166,333)
Total stockholders' equity	7,069	6,844	8,115	6,002	8,577	8,851	7,609	8,755	6,580	4,042	1,786	(1,852)
Total liabilities and equity	6,545	8,205	9,821	10,053	10,305	10,513	10,511	12,499	9,130	8,311	8,565	6,669
Common shares outstanding (cover page) thousands of shares	289,500	295,553	296,840	300,619	301,179	301,303	302,841	308,989	313,763	319,751	320,883	328,731

Cash flows

CSV

Fiscal quarters (BLGO's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Stock-based compensation	725*	855*	488	539*	237*	799*	615	492*	844*	1,014*	699	722*
Net cash from operating activities	(836)*	(2)*	481	(151)*	(1,620)*	(1,916)*	(1,830)	(2,118)*	(2,759)*	(1,590)*	(2,917)	(3,056)*
Net cash from investing activities	(205)*	(146)*	(863)	(358)*	(39)*	(57)*	0	192*	256*	(13)*	(32)	(160)*
Proceeds from issuing common stock	203*	656*	488	136*	(15)*	(15)*	(15)	808*	—	year only	256	391*
Net cash from financing activities	507*	761*	1,083	999*	764*	1,592*	866	2,833*	3,570*	952*	3,190	1,279*
Net change in cash	(533)*	497*	797	429*	(883)*	(334)*	(984)	907*	1,075*	(663)*	239	(1,934)*

Compare with peers

SIC 2800 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2800 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Biolargo	2,188	not reported	(3,056)*	328.7M	0.7 quarters	Q2 FY26 10-QJun 30, 2026
Liquidmetal Technologies	8,266	not reported	(193)*	917.3M	76.6 quarters	Q2 FY26 10-QJun 30, 2026
Loop Industries	836	117	(1,165)*	48.8M	0.7 quarters	Q2 FY27 10-QAug 31, 2026
CitroTech	2,519	281	(1,783)*	22.6M	1.4 quarters	Q2 FY26 10-Q/AJun 30, 2026
Ascent Industries	28,069	25,667	(2,296)*	9.0M	12.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.